<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36146884</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>19</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Reply to Alberts, P. Comment on "Hietanen et al. Cytolytic Properties and Genome Analysis of Rigvir<sup>®</sup> Oncolytic Virotherapy Virus and Other Echovirus 7 Isolates. <i>Viruses</i> 2022, <i>14</i>, 525".</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2078</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v14092078</ELocationID><Abstract><AbstractText>Our work focused on comparing the cellular effects of Rigvir to other echovirus 7 isolates, because originally Rigvir is also an echovirus 7 isolate [...].</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hietanen</LastName><ForeName>Eero</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-8548-3990</Identifier><AffiliationInfo><Affiliation>Institute of Biomedicine, University of Turku, Medisiina D, Kiinamyllynkatu 10, 20520 Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Susi</LastName><ForeName>Petri</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-9245-3271</Identifier><AffiliationInfo><Affiliation>Institute of Biomedicine, University of Turku, Medisiina D, Kiinamyllynkatu 10, 20520 Turku, Finland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Viruses. 2022 Mar 04;14(3):525. doi: 10.3390/v14030525</RefSource><PMID Version="1">35336934</PMID></CommentsCorrections><CommentsCorrections RefType="CommentOn"><RefSource>Viruses. 2022 Sep 19;14(9):2076. doi: 10.3390/v14092076</RefSource><PMID Version="1">36146882</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050130" MajorTopicYN="Y">Oncolytic Virotherapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050504" MajorTopicYN="Y">Oncolytic Viruses</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>23</Day><Hour>1</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36146884</ArticleId><ArticleId IdType="pmc">PMC9505120</ArticleId><ArticleId IdType="doi">10.3390/v14092078</ArticleId><ArticleId IdType="pii">v14092078</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alberts P. Comment on Hietanen et al. Cytolytic Properties and Genome Analysis of Rigvir® Oncolytic Virotherapy Virus and Other Echovirus 7 Isolates. Viruses 2022, 14, 525. Viruses. 2022;14:2076. doi: 10.3390/v14092076.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14092076</ArticleId><ArticleId IdType="pmc">PMC9506255</ArticleId><ArticleId IdType="pubmed">36146882</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>